Profile for United States of America Patent: 2005227919
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for United States of America Patent: 2005227919
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
⤷ Sign Up | Oct 11, 2024 | Astrazeneca | LYNPARZA | olaparib |
⤷ Sign Up | Sep 8, 2027 | Astrazeneca | LYNPARZA | olaparib |
⤷ Sign Up | Oct 11, 2024 | Astrazeneca | LYNPARZA | olaparib |
⤷ Sign Up | Aug 12, 2027 | Glaxosmithkline | ZEJULA | niraparib tosylate |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |